Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3

Pharmaceutical Research

Volumn 22, Issue 8, 2005, Pages 1406-1410

  Nishimuta, Haruka ^a   Tsujimoto, Masayuki ^a   Ogura, Kenichiro ^b   Hiratsuka, Akira ^b   Ohtani, Hisakazu ^a   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Drug food interaction; Enzyme inhibitors; Intestinal bioavailability; Ritodrine; Sulfotransferase

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; INTESTINE ENZYME; ISOENZYME; RECOMBINANT ENZYME; RITODRINE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A3; UNCLASSIFIED DRUG;

ARTICLE; BEVERAGE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG POTENCY; DRUG SULFATION; ENZYME INHIBITION; ESCHERICHIA COLI; EXAMINATION; FOOD INTAKE; GRAPEFRUIT JUICE; INTESTINE; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; ORANGE JUICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA;

ADRENERGIC BETA-AGONISTS; ALGORITHMS; ARYLSULFOTRANSFERASE; AUTORADIOGRAPHY; BEVERAGES; BIOLOGICAL AVAILABILITY; CITRUS; FOOD-DRUG INTERACTIONS; HUMANS; ISOENZYMES; KINETICS; RECOMBINANT PROTEINS; RITODRINE; SULFOTRANSFERASES; TEA;

EID: 23844543826     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-5263-y     Document Type: Article

References (18)

1. J. D. Hosenpud M. J. Morton J. P. O'Grady 1983 Cardiac stimulation during ritodrine hydrochloride tocolytic therapy Obstet. Gynecol. 62 52 58
2. W. T. Brashear B. R. Kuhnert R. Wei 1990 Structural determination of the conjugated metabolites of ritodrine Drug Metab. Dispos. 18 488 493
3. W. T. Brashear B. R. Kuhnert R. Wei 1988 Maternal and neonatal urinary excretion of sulfate and glucuronide ritodrine conjugates Clin. Pharmacol. Ther. 44 634 641
4. G. M. Pacifici M. C. Quilici B. Giulianetti R. Spisni M. Nervi L. Giuliani R. Gomeni 1998 Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability Eur. J. Drug Metab. Pharmacokinet. 23 67 74
5. M. Cappiello L. Giuliani G. M. Pacifici 1990 Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa Pharmacology 40 69 76
6. W. E. Bronner G. R. Beecher 1998 Method for determining the content of catechins in tea infusions by high-performance liquid chromatography J. Chromatogr. A 805 137 142
7. M. W. Coughtrie L. E. Johnston 2001 Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance Drug Metab. Dispos. 29 522 528
8. T. Nishiyama K. Ogura H. Nakano T. Kaku E. Takahashi Y. Ohkubo K. Sekine A. Hiratsuka S. Kadota T. Watabe 2002 Sulfation of environmental estrogens by cytosolic human sulfotransferases Drug Metab. Pharmacokinet. 17 221 228
9. H. Nakano K. Ogura E. Takahashi T. Harada T. Nishiyama K. Muro A. Hiratsuka S. Kadota T. Watabe 2004 Regioselective monosulfation and disulfation of the phytoestrogens daidzein and genistein by human liver sulfotransferases Drug Metab. Pharmacokinet. 19 216 226
10. R. D. Sekura C. J. Marcus E. S. Lyon W. B. Jakoby 1979 Assay of sulfotransferases Anal. Biochem. 95 82 86
11. R. S. Sundaram C. Szumlanski D. Otterness J. A. van Loon R. M. Weinshilboum 1989 Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form Drug Metab. Dispos. 17 255 264
12. B. Ma M. Shou M. L. Schrag 2003 Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro Drug Metab. Dispos. 31 1300 1305
13. G. Chen D. Zhang N. Jing S. Yin C. N. Falany A. Radominska-Pandya 2003 Human gastrointestinal sulfotransferases: identification and distribution Toxicol. Appl. Pharmacol. 187 186 197
14. J. Wang J. L. Falany C. N. Falany 1998 Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver Mol. Pharmacol. 53 274 282
15. G. Hochhaus H. Mollmann 1992 Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol Int. J. Clin. Pharmacol. Ther. Toxicol. 30 342 362
16. D. D. Shen K. L. Kunze K. E. Thummel 1997 Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction Adv. Drug Deliv. Rev. 27 99 127
17. R. Hildebrandt B. Wagner K. Preiss-Nowzohour U. Gundert-Remy 1994 Fenoterol metabolism in man: sulphation versus glucuronidation Xenobiotica 24 71 77
18. K. Tegner H. T. Nilsson C. G. Persson K. Persson A. Ryrfeldt 1984 Elimination pathways of terbutaline Eur. J. Respir. Dis., Suppl. 134 93 100